Compositions of lotus leaf extract, chrysanthemum morifolium extract, and PU'er tea extract, methods and uses of the same
Compositions of lotus leaf, Chrysanthemum morifolium, and Pu'er tea extracts activate GLP-1R receptors and inhibit pancreatic lipase, addressing obesity and diabetes through synergistic weight loss and metabolic benefits.
WO2026060240A9PCT designated stage Publication Date: 2026-06-18ACCESS BUSINESS GROUP INTERNATIONAL LLC
Patent Information
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- ACCESS BUSINESS GROUP INTERNATIONAL LLC
- Filing Date
- 2025-09-12
- Publication Date
- 2026-06-18
AI Technical Summary
⚠Technical Problem
There is a need for safe and effective compositions and methods for weight loss management and obesity, as well as related conditions such as type 2 diabetes and metabolic disorders, as existing treatments are inadequate.
⚗Method used
Compositions comprising lotus leaf extract, Chrysanthemum morifolium extract, and Pu'er tea extract, which exhibit significant agonism on GLP-1R receptors and synergistic pancreatic lipase inhibition, are developed.
🎯Benefits of technology
The combination of these extracts demonstrates enhanced weight loss support, blood sugar level reduction, and lipid management, offering a therapeutic effect greater than individual extracts, with potential for treating type 2 diabetes.
✦ Generated by Eureka AI based on patent content.
Smart Images
Figure US2025046149_18062026_PF_FP_ABST
Abstract
Described herein are compositions including at least one of lotus leaf extract (LLE), Chrysanthemum morifolium extract (CME), and Pu'er tea extract (PTE) having an agonistic effect on glucagon-like peptide-1 receptor (GLP-1R). Also, described herein are compositions including a mixture of LLE, CME and PTE. Methods of using the described compositions, e.g., for supporting weight loss efforts in a subject in need of thereof are also described.
Need to check novelty before this filing date? Find Prior Art